Latest Stories

Cigna Sees Up to $600 Million Earnings Hit From Pharmacy Plan

Cigna Group’s plan to end drug rebates will reduce earnings by $500 million to $600 million, the company’s chief executive officer said at a congressional hearing Thursday in which the country’s biggest health insurers were grilled about health-care affordability.

Practitioner Insights

View More Insights
Robert Luther III
George Mason University Antonin Scalia Law School

EXPLORE BLOOMBERG LAW

Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: